Original language | English |
---|---|
Pages (from-to) | 149-152 |
Number of pages | 4 |
Journal | Journal of Nuclear Medicine |
Volume | 64 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2023 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Nuclear Medicine, Vol. 64, No. 1, 01.01.2023, p. 149-152.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI
T2 - Endorsed by the American Heart Association
AU - Ruddy, Terrence D.
AU - Al-Mallah, Mouaz
AU - Arrighi, James A.
AU - Bois, John P.
AU - Bluemke, David A.
AU - Di Carli, Marcelo F.
AU - Dilsizian, Vasken
AU - Gropler, Robert J.
AU - Jadvar, Hossein
AU - Malhotra, Saurabh
AU - Pelletier-Galarneau, Matthieu
AU - Schindler, Thomas H.
AU - Woodard, Pamela K.
AU - Chareonthaitawee, Panithaya
N1 - Funding Information: Endorsed by the American College of Radiology (ACR), American Heart Association (AHA), the American Society of Nuclear Cardiology (ASNC), the Society for Cardiovascular Magnetic Resonance (SCMR), and Society of Nuclear Medicine and Molecular Imaging (SNMMI) Funding Information: Terrence D. Ruddy: GEHealthcare-Research Grant. Mouaz Al-Mallah: Research support: Siemens; Consultant: Pfizer, Jubulant, Philips. James A. Arrighi, John P. Bois, David A. Bluemke, Vasken Dilsizian: Nothing to disclose. Marcelo F. Di Carli: Institutional Research Grant: Gilead Sciences. Robert J. Gropler: GE-Healthcare and Medtrace—Research grants; AHA-editor stipend. Hossein Jad-var: Radiomedix-Advisory Board; Lantheus-Speaker’s Bureau; Blue Earth Diagnostics-Consultant; Bayer-Consultant. Saurabh Malhotra: Speakers Bureau—Pfizer Inc, and Alnylam; Advisory Board—Alnylam and BridgeBio. Matthieu Pelletier-Galarneau: Jubilant Radiopharma-Consulting, Research Funds. M.P.-G. is supported by a Junior 1 Research Award from the Fonds de Recherche du Québec—Santé (FRQS). Thomas H. Schindler: GE: multicenter Flupiridaz cardiac PET study. Pamela K. Woodard: None related to this article. Other research funding: NIH, Siemens, Bayer. Panithaya Chareonthaitawee: BioClinica-Consulting; UptoDate—Royalties.
PY - 2023/1/1
Y1 - 2023/1/1
UR - http://www.scopus.com/inward/record.url?scp=85145526140&partnerID=8YFLogxK
U2 - 10.2967/jnumed.122.264200
DO - 10.2967/jnumed.122.264200
M3 - Article
C2 - 36599473
AN - SCOPUS:85145526140
SN - 0161-5505
VL - 64
SP - 149
EP - 152
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 1
ER -